Response to SARS‐CoV‐2 vaccination and antibodies persistence in multiple myeloma patients
N/A This article is protected by copyright. All rights reserved.
Saved in:
Published in | Hematological oncology Vol. 41; no. 1; pp. 210 - 212 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.02.2023
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | N/A
This article is protected by copyright. All rights reserved. |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/hon.3051 |
ISSN: | 0278-0232 1099-1069 |
DOI: | 10.1002/hon.3051 |